# ReMindCare App for Patients From First Episode of Psychosis Unit.

> **NCT03807388** · NA · UNKNOWN · sponsor: **Instituto de Investigacion Sanitaria INCLIVA** · enrollment: 140 (estimated)

## Conditions studied

- Psychosis
- Schizophrenia
- Psychotic Disorders
- Delirium
- Hallucinations
- Adherence, Medication
- Treatment Side Effects

## Interventions

- **DEVICE:** ReMindCare Intervention Group
- **OTHER:** Treatment as Usual

## Key facts

- **NCT ID:** NCT03807388
- **Lead sponsor:** Instituto de Investigacion Sanitaria INCLIVA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2020-05
- **Final completion:** 2023-09
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2019-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807388, "ReMindCare App for Patients From First Episode of Psychosis Unit.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03807388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*